for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Ascendis Health Ltd

ASCJ.J

Latest Trade

485.00ZAc

Change

5.00(+1.04%)

Volume

378,518

Today's Range

480.00

 - 

492.00

52 Week Range

305.00

 - 

915.00

As of on the Johannesburg Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
480.00
Open
480.00
Volume
378,518
3M AVG Volume
3.87
Today's High
492.00
Today's Low
480.00
52 Week High
915.00
52 Week Low
305.00
Shares Out (MIL)
485.50
Market Cap (MIL)
2,349.46
Forward P/E
3.45
Dividend (Yield %)
--

Latest Developments

More

Ascendis Health Says In Negotiations Over Potential Disposal Of Remedica

Ascendis Health Appoints Mark Sardi As CEO

Ascendis Health Says Disposal Of Businesses Within Biosciences Division Unconditional

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Ascendis Health Ltd

Ascendis Health Limited is a health and care brands company. The Company operates through four segments: Consumer Brands, Pharma-Med, Phyto-Vet and International. Its Consumer Brands segment consists of health and personal care products sold to the public, primarily at the retail store level. It offers over the counter (OTC) medicines and consumer brands products, including vitamins and minerals, homeopathic, herbal products, dermaceuticals, functional foods, functional super foods, sports nutrition, health beverages, weight management and therapeutic cosmetics. Its Pharma-Med segment consists of the sale of prescription and selected OTC pharmaceuticals, and includes medical devices. The Phyto-Vet segment supplies health and care products to the plant and animal markets. It manufactures and supplies over 3,500 products. The International segment sells health and personal care products, prescription and selected OTC pharmaceuticals and medical devices operating in the European market.

Industry

Major Drugs

Contact Info

31 Georgian Crescent East

+27.11.0369600

http://www.ascendis.co.za/

Executive Leadership

Andrew Brian Marshall

Chairman of the Board

Kieron Futter

Chief Financial Officer, Executive Director

Marnus Sonnekus

Interim Chief Operating Officer

Cornelle Van Graan

Head of Direct Selling

A. Sims

Company Secretary

Key Stats

1.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, ZAR)

2016

3.9K

2017

6.4K

2018

7.7K

2019(E)

7.7K
EPS (ZAR)

2016

1.200

2017

1.457

2018

1.360

2019(E)

1.390
Price To Earnings (TTM)
5.06
Price To Sales (TTM)
0.30
Price To Book (MRQ)
0.34
Price To Cash Flow (TTM)
2.81
Total Debt To Equity (MRQ)
82.38
LT Debt To Equity (MRQ)
65.06
Return on Investment (TTM)
3.90
Return on Equity (TTM)
3.07

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up